What's new in fungal infection in leukemic patients (Q40722965)

23 September 2017

1 reference

title

What's new in fungal infection in leukemic patients (English)

1 reference

23 September 2017

1 reference

Bodey GP

1

1 reference

23 September 2017

1 January 1993

1 reference

23 September 2017

1 reference

23 September 2017

11 Suppl 2

1 reference

23 September 2017

127-135

1 reference

Fever and infection in leukemic patients.A study of 494 consecutive patients

23 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Bacteremia and fungemia in patients with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

The emergence of fungi as major hospital pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Invasive aspergillosis. Progress in early diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Fusarium. A newly recognized fungal pathogen in immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Alternaria: a sinonasal pathogen of immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

21 January 2018

Fungal blood cultures

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Rapid intravenous infusion of amphotericin B: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Amphotericin B nephrotoxicity in humans decreased by salt repletion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Sodium protects against nephrotoxicity in patients receiving amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Pentoxifylline in amphotericin B toxicity rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

21 January 2018

Azole Antifungal Agents

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Hepatosplenic candidiasis: successful treatment with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Treatment of invasive aspergillosis with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309064272

10.3109/10428199309064272

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8124224